Growth Metrics

Castle Biosciences (CSTL) Deferred Taxes (2021 - 2026)

Castle Biosciences' Deferred Taxes history spans 5 years, with the latest figure at -$907000.0 for Q4 2025.

  • On a quarterly basis, Deferred Taxes rose 60.68% to -$907000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.2 million, a 544.54% decrease, with the full-year FY2025 number at -$6.2 million, down 544.54% from a year prior.
  • Deferred Taxes hit -$907000.0 in Q4 2025 for Castle Biosciences, down from $116000.0 in the prior quarter.
  • Over the last five years, Deferred Taxes for CSTL hit a ceiling of $5.2 million in Q3 2024 and a floor of -$8.7 million in Q4 2021.
  • Historically, Deferred Taxes has averaged -$1.2 million across 5 years, with a median of -$770000.0 in 2025.
  • Biggest five-year swings in Deferred Taxes: surged 99.57% in 2022 and later crashed 877.54% in 2024.
  • Tracing CSTL's Deferred Taxes over 5 years: stood at -$8.7 million in 2021, then surged by 99.57% to -$38000.0 in 2022, then plummeted by 521.05% to -$236000.0 in 2023, then crashed by 877.54% to -$2.3 million in 2024, then skyrocketed by 60.68% to -$907000.0 in 2025.
  • Business Quant data shows Deferred Taxes for CSTL at -$907000.0 in Q4 2025, $116000.0 in Q3 2025, and -$4.7 million in Q2 2025.